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Antiphospholipid antibody syndrome (APS) is a rare
condition in childhood. Some cases have been reported
in neonates, and it is believed that most of them result
from a transplacental transfer of antiphospholipid anti-
bodies (APLA) from the mother to the foetus.
Case
the first child of a 28 year healthy mother with no his-
tory of auto-immunity nor thrombotic events. The preg-
nancy was complicated by diabetes. The birth arose
after a 39 weeks pregnancy, by normal vaginal delivery.
The male newborn weighted 3830 g (P90). The clinical
examination was normal. The third day, he exhibited
clonic seizure of the right hemi-body. EEG demon-
strated left temporal spikes. Cerebral ultrasonography
and MRI showed infarction in the territory of the left
middle cerebral artery. Prothrombin time and activated
partial thromboplastin time, antithrombin III, protein C,
protein S and homocystine levels were normal. There
was no mutation of the factor II or V. Serology for anti-
phospholipid antibodies and detection for antib2gp1
were negative in the child and the mother serum. One
year later, a new systematic screening showed a high
titer of anticardiolipid antibodies (Table 1). Antinuclear
antibodies were negative. None of those antibodies were
found in the maternal serum. All those features per-
sisted on a second testing 12 weeks later.
Conclusion
Contrary to what is usually thought, neonatal APS not
always result from the transplacental transfer of APLA.
Our case highlights the importance of considering the
maternal status when reporting on neonatal APS; and of
considering the possibly of APS even in the absence of
antibodies in the mother.
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Table 1 Biological features of the child and the mother
Time after birth
5 days 1 year
Normal values Child Mother Child Mother
KCT (sec) 43/34 52/35 36/36
Anticardiolipid AB IgM (UMPL/ml) <10 <5 <1 4 <1
IgG (UGPL/ml) <11 <5 <1 191 <1
Anti b2gpI AB IgM <10 <5 <1 <1 <1
IgG <20 <5 <1 258 <1
VDRL - - NEG NEG
TPHA - NEG NEG
Merlin et al. Pediatric Rheumatology 2011, 9(Suppl 1):P263
http://www.ped-rheum.com/content/9/S1/P263
© 2011 Merlin et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Author details
1CHU Clermont-Ferrand, INSERM CIC 501, 63003 Clermont-Ferrand, France.
2CHU Saint-Etienne, Hôpital Nord, 42000 Saint-Etienne, France.
Published: 14 September 2011
doi:10.1186/1546-0096-9-S1-P263
Cite this article as: Merlin et al.: Infantile de novo primary
antiphospholipid syndrome revealed by neonatal stroke. Pediatric
Rheumatology 2011 9(Suppl 1):P263.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Merlin et al. Pediatric Rheumatology 2011, 9(Suppl 1):P263
http://www.ped-rheum.com/content/9/S1/P263
Page 2 of 2